ImmunityBio's total assets for Q were $504.45M, an increase of 16.66% from the previous quarter. IBRX total liabilities were $1.09B for the fiscal quarter, a 29.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.